Drug Enforcement Administration, 50042-50043 [2015-20344]
Download as PDF
50042
Federal Register / Vol. 80, No. 159 / Tuesday, August 18, 2015 / Notices
Controlled substance
Schedule
Psilocyn (7438) ............................................................................................................................................................................................
5-Methoxy-N,N-diisopropyltryptamine (7439) ..............................................................................................................................................
N-Ethyl-1-phenylcyclohexylamine (7455) ....................................................................................................................................................
1-(1-Phenylcyclohexyl)pyrrolidine (7458) ....................................................................................................................................................
1-[1-(2-Thienyl)cyclohexyl]piperidine (7470) ...............................................................................................................................................
2-(2,5-Dimethoxy-4-ethylphenyl) ethanamine (2C–E) (7509) .....................................................................................................................
2-(2,5-Dimethoxyphenyl) ethanamine (2C–H) (7517) .................................................................................................................................
2-(4-lodo-2,5-dimethoxyphenyl) ethanamine (2C–I) (7518) ........................................................................................................................
2-(4-Isopropylthio)-2,5-dimethoxyphenyl) ethanamine (2C–T–4) (7532) ....................................................................................................
Dihydromorphine (9145) ..............................................................................................................................................................................
Heroin (9200) ...............................................................................................................................................................................................
Normorphine (9313) ....................................................................................................................................................................................
Methamphetamine (1105) ...........................................................................................................................................................................
1-Phenylcyclohexylamine (7460) .................................................................................................................................................................
Phencyclidine (7471) ...................................................................................................................................................................................
Phenylacetone (8501) .................................................................................................................................................................................
1-Piperidinocyclohexanecarbonitrile (8603) ................................................................................................................................................
Cocaine (9041) ............................................................................................................................................................................................
Codeine (9050) ............................................................................................................................................................................................
Dihydrocodeine (9120) ................................................................................................................................................................................
Ecgonine (9180) ..........................................................................................................................................................................................
Meperidine intermediate-B (9233) ...............................................................................................................................................................
Morphine (9300) ..........................................................................................................................................................................................
Noroxymorphone (9668) ..............................................................................................................................................................................
The company plans to manufacture
high purity drug standards used for
analytical applications only in clinical,
toxicological, and forensic laboratories
and for distribution to its customers.
Dated: August 10, 2015.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[FR Doc. 2015–20283 Filed 8–17–15; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
[Docket No. 13–29]
Drug Enforcement Administration
asabaliauskas on DSK5VPTVN1PROD with NOTICES
Matthew Valentine/Liar Catchers;
Order
On April 5, 2013, the Deputy
Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration, issued an Order to
Show Cause to Matthew Valentine
(hereinafter, Applicant), of Lexington,
Kentucky. The Show Cause Order
proposed the denial of Applicant’s
pending application for a DEA
Certificate of Registration as a
Researcher, which would authorize
Applicant to possess and use controlled
substances as a canine handler, on the
ground that his registration would be
inconsistent with the public interest. GX
1, at 1 (citing 21 U.S.C. 823(f)).
On April 29, 2013, Applicant, acting
pro se, filed a request for a hearing with
the DEA Office of Administrative Law
Judges. GX 2. After the matter was
assigned to an Administrative Law
Judge (ALJ), Applicant submitted a
VerDate Sep<11>2014
17:02 Aug 17, 2015
Jkt 235001
letter in which he requested to
withdraw his application. GX 3.
Therein, Applicant stated that he was
‘‘not in a position to fight this legal
battle at this time.’’ Id. A few weeks
later, Applicant requested a stay until
May 31, 2013, see GX 4, which was
granted by the ALJ. See GX 5.
Upon presentation of Applicant’s
withdrawal request to the Office of
Diversion Control (OD), the latter
advised Government Counsel that it
would accept the request only if
Applicant agreed not to reapply for
three years. Request for Final Agency
Action, at 3. Applicant rejected OD’s
offer. Id. Thereafter, OD made a
subsequent offer that would have
allowed Applicant to withdraw if he
agreed not to reapply for two years. Id.
Applicant also rejected this offer. Id.
According to Government Counsel, on
May 22, 2012, OD, ‘‘without providing
a basis for its decision,’’ notified the
former that it had rejected Applicant’s
withdrawal request and ‘‘instructed
Chief Counsel to take the matter to
hearing.’’ Id. The next day, Government
Counsel notified the ALJ of OD’s
decision. The ALJ then vacated the stay
and set the matter for hearing. GX 7, at
1–2.
On May 29, 2013, Applicant
submitted a request to waive his right to
a hearing and submitted various
documents in support of his
application. GX 8. The ALJ then ordered
that the proceeding be terminated. GX 9.
Thereafter, on October 29, 2013, the
Government submitted a Request for
Final Agency Action. Req. for Final
Agency Action, at 15. Therein, the
PO 00000
Frm 00058
Fmt 4703
Sfmt 4703
I
I
I
I
I
I
I
I
I
I
I
I
II
II
II
II
II
II
II
II
II
II
II
II
Government sought the denial of
Applicant’s application. Id. at 1.
Upon review, the then-Administrator
denied the Government’s request. Order
of the Administrator, at 3 (May 2, 2015)
(hereinafter, Order). The thenAdministrator specifically explained
that under a DEA regulation, ‘‘‘[a]n
application may be amended or
withdrawn with permission of the
Administrator at any time where good
cause is shown by the applicant or
where the amendment or withdrawal is
in the public interest.’’’ Id. at 2 (quoting
21 CFR 1301.16(a)). The thenAdministrator also relied on section
555(e) of the Administrative Procedure
Act, which provides that:
Prompt notice shall be given of the denial
in whole or in part of a written application,
petition, or other request of an interested
person made in connection with any agency
proceedings. Except in affirming a prior
denial or when the denial is self-explanatory,
the notice shall be accompanied by a brief
statement of the grounds for denial.
5 U.S.C. 555(e) (quoted in Order, at 2).
Based on the plain language of section
555(e), the then-Administrator held that
Applicant’s withdrawal request clearly
was a ‘‘request of an interested person
made in connection with [an] agency
proceeding.’’ Order, at 2. She further
noted that the grounds for denying
Applicant’s withdrawal request were
not ‘‘self-explanatory,’’ and were, in
fact, ‘‘totally unknown.’’ Id.
Accordingly, the then-Administrator
held that the Office of Diversion Control
was required to provide Applicant with
a ‘‘ ‘notice,’ ’’ which was ‘‘ ‘accompanied
by a brief statement of the grounds for
E:\FR\FM\18AUN1.SGM
18AUN1
Federal Register / Vol. 80, No. 159 / Tuesday, August 18, 2015 / Notices
denial’ ’’ of his withdrawal request. Id.
at 3 (quoting 5 U.S.C. 555(e)).
Because the Office of Diversion
Control had not complied with section
555(e), the then-Administrator denied
the Government’s Request for Final
Agency Action. Id. The thenAdministrator returned the record to the
Government’s Counsel, with the
instruction that its Request should not
be re-submitted until such time as the
Office of Diversion Control complied
with 5 U.S.C. 555(e) and explained why
Applicant has not demonstrated good
cause to withdraw his application, as
well as why the withdrawal is not in the
public interest. Id.
On August 7, 2015, Government
Counsel filed a Request for Dismissal of
Order to Show Cause. Therein,
Government Counsel represents that on
July 30, 3015, the Office of Diversion
Control had decided to allow
Respondent to withdraw his
application. The Government therefore
requests an Order dismissing the Show
Cause Order.
Because the Office of Diversion
Control has granted Respondent’s
withdrawal request, there is no longer
an application to act upon and the case
is now moot. See Thomas E. Mitchell,
76 FR 20032, 20033 (2011).
Accordingly, I grant the Government’s
Request and dismiss the Order to Show
Cause.
Order
Pursuant to the authority vested in me
by 21 U.S.C. 823(f), as well as 28 CFR
0.100(b), I order that the Order to Show
Cause issued to Matthew Valentine/Liar
Catchers be, and it hereby is, dismissed.
This Order is effective immediately.
Dated: August 10, 2015.
Chuck Rosenberg,
Acting-Administrator.
[FR Doc. 2015–20344 Filed 8–17–15; 8:45 am]
BILLING CODE 4410–09–P
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/ODXL, 8701
Morrissette Drive, Springfield, Virginia
22152. Request for hearings should be
sent to: Drug Enforcement
Administration, Attention: Hearing
Clerk/LJ, 8701 Morrissette Drive,
Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Deputy Assistant
Administrator of the DEA Office of
Diversion Control (‘‘Deputy Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.33(a), this is notice that on April
23, 2015, Austin Pharma LLC, 811
Paloma Drive, Suite C, Round Rock,
Texas 78665–2402 applied to be
registered as a bulk manufacturer of the
following basic classes of controlled
substances:
ADDRESSES:
Controlled substance
Marihuana (7360) .........................
Tetrahydrocannabinols (7370) .....
Schedule
I
I
The company plans to manufacture
bulk synthetic active pharmaceutical
ingredients (APIs) for product
development and distribution to its
customers. No other activity for this
drug code is authorized for this
registration.
Drug Enforcement Administration
Dated: August 10, 2015.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[Docket No. DEA–392]
[FR Doc. 2015–20284 Filed 8–17–15; 8:45 am]
DEPARTMENT OF JUSTICE
BILLING CODE 4410–09–P
asabaliauskas on DSK5VPTVN1PROD with NOTICES
Bulk Manufacturer of Controlled
Substances Application: Austin
Pharma LLC
ACTION:
DEPARTMENT OF JUSTICE
[OMB Number 1121–0335]
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration in
accordance with 21 CFR 1301.33(a) on
or before October 19, 2015.
DATES:
VerDate Sep<11>2014
17:02 Aug 17, 2015
Jkt 235001
Agency Information Collection
Activities; Proposed eCollection
eComments Requested; National
Motor Vehicle Title Information System
(NMVTIS)
Bureau of Justice Assistance,
Department of Justice.
AGENCY:
PO 00000
Frm 00059
Fmt 4703
Sfmt 4703
ACTION:
50043
30-Day notice.
The Department of Justice,
Office of Justice Programs, Bureau of
Justice Assistance, will submit the
following information collection request
for review and clearance in accordance
with the Paperwork Reduction Act of
1995. The proposed information
collection was previously published in
80 FR 32180, on June 5, 2015, allowing
for a 60-day comment period.
SUMMARY:
Comments are encouraged and
will be accepted for an additional 30
days until September 17, 2015.
DATES:
If
you have additional comments,
suggestions, or need a copy of the
proposed information collection
instrument with instructions or
additional information, please contact
C. Casto at 1–202–353–7193, Bureau of
Justice Assistance, Office of Justice
Programs, U. S. Department of Justice,
810 7th Street NW., Washington, DC,
20531 or by email at Chris.Casto@
usdoj.gov. You may also contact the
Office of Management and Budget,
Office of Information and Regulatory
Affairs, Attention Department of Justice
Desk Officer, Washington, DC 20503.
Additionally, comments may be
submitted via email to OIRA_
submissions@omb.eop.gov.
FOR FURTHER INFORMATION CONTACT:
Written
comments and suggestions from the
public and affected agencies concerning
the proposed collection of information
are encouraged. Your comments should
address one or more of the following
four points:
SUPPLEMENTARY INFORMATION:
—Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the National Motor
Vehicle Title Information System
(NMVTIS), including whether the
information will have practical utility;
—Evaluate the accuracy of the agency’s
estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
—Evaluate whether and if so how the
quality, utility, and clarity of the
information to be collected can be
enhanced; and
—Minimize the burden of the collection
of information on those who are to
respond, including through the use of
appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms
of information technology, e.g.,
permitting electronic submission of
responses.
E:\FR\FM\18AUN1.SGM
18AUN1
Agencies
[Federal Register Volume 80, Number 159 (Tuesday, August 18, 2015)]
[Notices]
[Pages 50042-50043]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-20344]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
[Docket No. 13-29]
Drug Enforcement Administration
Matthew Valentine/Liar Catchers; Order
On April 5, 2013, the Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement Administration, issued an Order to
Show Cause to Matthew Valentine (hereinafter, Applicant), of Lexington,
Kentucky. The Show Cause Order proposed the denial of Applicant's
pending application for a DEA Certificate of Registration as a
Researcher, which would authorize Applicant to possess and use
controlled substances as a canine handler, on the ground that his
registration would be inconsistent with the public interest. GX 1, at 1
(citing 21 U.S.C. 823(f)).
On April 29, 2013, Applicant, acting pro se, filed a request for a
hearing with the DEA Office of Administrative Law Judges. GX 2. After
the matter was assigned to an Administrative Law Judge (ALJ), Applicant
submitted a letter in which he requested to withdraw his application.
GX 3. Therein, Applicant stated that he was ``not in a position to
fight this legal battle at this time.'' Id. A few weeks later,
Applicant requested a stay until May 31, 2013, see GX 4, which was
granted by the ALJ. See GX 5.
Upon presentation of Applicant's withdrawal request to the Office
of Diversion Control (OD), the latter advised Government Counsel that
it would accept the request only if Applicant agreed not to reapply for
three years. Request for Final Agency Action, at 3. Applicant rejected
OD's offer. Id. Thereafter, OD made a subsequent offer that would have
allowed Applicant to withdraw if he agreed not to reapply for two
years. Id. Applicant also rejected this offer. Id.
According to Government Counsel, on May 22, 2012, OD, ``without
providing a basis for its decision,'' notified the former that it had
rejected Applicant's withdrawal request and ``instructed Chief Counsel
to take the matter to hearing.'' Id. The next day, Government Counsel
notified the ALJ of OD's decision. The ALJ then vacated the stay and
set the matter for hearing. GX 7, at 1-2.
On May 29, 2013, Applicant submitted a request to waive his right
to a hearing and submitted various documents in support of his
application. GX 8. The ALJ then ordered that the proceeding be
terminated. GX 9. Thereafter, on October 29, 2013, the Government
submitted a Request for Final Agency Action. Req. for Final Agency
Action, at 15. Therein, the Government sought the denial of Applicant's
application. Id. at 1.
Upon review, the then-Administrator denied the Government's
request. Order of the Administrator, at 3 (May 2, 2015) (hereinafter,
Order). The then-Administrator specifically explained that under a DEA
regulation, ```[a]n application may be amended or withdrawn with
permission of the Administrator at any time where good cause is shown
by the applicant or where the amendment or withdrawal is in the public
interest.''' Id. at 2 (quoting 21 CFR 1301.16(a)). The then-
Administrator also relied on section 555(e) of the Administrative
Procedure Act, which provides that:
Prompt notice shall be given of the denial in whole or in part
of a written application, petition, or other request of an
interested person made in connection with any agency proceedings.
Except in affirming a prior denial or when the denial is self-
explanatory, the notice shall be accompanied by a brief statement of
the grounds for denial.
5 U.S.C. 555(e) (quoted in Order, at 2).
Based on the plain language of section 555(e), the then-
Administrator held that Applicant's withdrawal request clearly was a
``request of an interested person made in connection with [an] agency
proceeding.'' Order, at 2. She further noted that the grounds for
denying Applicant's withdrawal request were not ``self-explanatory,''
and were, in fact, ``totally unknown.'' Id. Accordingly, the then-
Administrator held that the Office of Diversion Control was required to
provide Applicant with a `` `notice,' '' which was `` `accompanied by a
brief statement of the grounds for
[[Page 50043]]
denial' '' of his withdrawal request. Id. at 3 (quoting 5 U.S.C.
555(e)).
Because the Office of Diversion Control had not complied with
section 555(e), the then-Administrator denied the Government's Request
for Final Agency Action. Id. The then-Administrator returned the record
to the Government's Counsel, with the instruction that its Request
should not be re-submitted until such time as the Office of Diversion
Control complied with 5 U.S.C. 555(e) and explained why Applicant has
not demonstrated good cause to withdraw his application, as well as why
the withdrawal is not in the public interest. Id.
On August 7, 2015, Government Counsel filed a Request for Dismissal
of Order to Show Cause. Therein, Government Counsel represents that on
July 30, 3015, the Office of Diversion Control had decided to allow
Respondent to withdraw his application. The Government therefore
requests an Order dismissing the Show Cause Order.
Because the Office of Diversion Control has granted Respondent's
withdrawal request, there is no longer an application to act upon and
the case is now moot. See Thomas E. Mitchell, 76 FR 20032, 20033
(2011). Accordingly, I grant the Government's Request and dismiss the
Order to Show Cause.
Order
Pursuant to the authority vested in me by 21 U.S.C. 823(f), as well
as 28 CFR 0.100(b), I order that the Order to Show Cause issued to
Matthew Valentine/Liar Catchers be, and it hereby is, dismissed. This
Order is effective immediately.
Dated: August 10, 2015.
Chuck Rosenberg,
Acting-Administrator.
[FR Doc. 2015-20344 Filed 8-17-15; 8:45 am]
BILLING CODE 4410-09-P